In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals
William E. Fitzsimmons(American Association of Colleges of Pharmacy), Catherine Z. Chen(National Institutes of Health), Tracy L. Hartman(ImQuest BioSciences (United States)), Michelle Mendenhall(Utah State University)
Cited by 3
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225
RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
|SLAS DISCOVERY|2020|192